Last Updated:
Name Designation Appointment Date Status
Thaduri Srivani

Appointed as Director since May 2021

Director 25-May-2021 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Genotech Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Ravi Kumar Pericherla

Appointed as Director since July 2018

Director 13-Jul-2018 Current
Murari Rajakumari

Appointed as Director since May 2021

Director 25-May-2021 Current
Suryanarayana Kolagani

Appointed as Director since June 2018

Director 15-Jun-2018 Current

People Timeline

Explore the timeline of key personnel in Genotech Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address D.No: 8-16-26/1, Sowbhagyanagar Colony L.B.Nagar, Saroornagar,, Hyderabad Telangana, 500040, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Genotech Pharmaceuticals Private Limited through their registered address at D.No: 8-16-26/1, Sowbhagyanagar Colony L.B.Nagar, Saroornagar,, Hyderabad Telangana, 500040, India, or via their website at genotechpharma.com. Social media links are also provided where applicable.
The current directors of Genotech Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • THADURI SRIVANI
  • RAVI KUMAR PERICHERLA
  • MURARI RAJAKUMARI
  • SURYANARAYANA KOLAGANI
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available